Anti-Persisters Activity of Lacticaseibacillus rhamnosus Culture Filtrates against Pseudomonas aeruginosa in Artificial Sputum Medium
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137113 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Marta Bianchi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via S. Zeno 37, 56123 Pisa, Italy. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Sputum, Biofilms, Lacticaseibacillus rhamnosus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Recovery and Resilience Plan, part of the Next Gener-ation EU program, PNRR THE-Tuscany Health Ecosystem; and Spoke 7-Innovating Transla-tional Me…, The National Recovery and Resilience Plan, part of the Next Generation EU program, PNRR THE—Tuscany Health Ecosystem; Spoke 7—Innovating Translational Medicine….
Abstract (Originalsprache)
Persisters are antibiotic-tolerant bacteria, playing a role in the recalcitrance and relapse of many bacterial infections, including P. aeruginosa pulmonary infections in Cystic Fibrosis (CF) patients. Among novel antimicrobial strategies, the use of probiotics and their products is emerging as a particularly promising approach. The aim of this study was to evaluate the anti-persisters activity of culture filtrate supernatants of Lacticaseibacillus rhamnosus (LRM-CFS) against P. aeruginosa in artificial sputum medium (ASM), which resembles the CF lung environment. Planktonic persisters of two clinical strains of P. aeruginosa (PaCF1 and PaCF4) were obtained following two different procedures: (i) exposing stationary-phase cultures to cyanide m-chlorophenylhydrazone (CCCP) in LB medium; (ii) incubating stationary-phase cultures with high doses of tobramycin (128-fold MIC) in ASM. In addition, persisters from biofilm were obtained by exposing 48 h old biofilm of P. aeruginosa to 128 x MIC of ciprofloxacin. LRM-CFS at dilutions of 1:6 and 1:4 resulted in being bactericidal in ASM against both PaCF1 and PaCF4 persisters obtained after CCCP or tobramycin treatment. Moreover, LRM-CFS at dilution 1:4 caused a reduction of antibiotic-tolerant bacteria in the biofilm of both P. aeruginosa strains. Overall, LRM-CFS represents a promising adjuvant therapeutic strategy against P. aeruginosa recalcitrant infections in CF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via S. Zeno 37, 56123 Pisa, Italy.
ORCID-Profile: Marta Bianchi, Semih Esin, Giovanna Batoni, Giuseppantonio Maisetta
Förderung
- The National Recovery and Resilience Plan, part of the Next Gener-ation EU program, PNRR THE-Tuscany Health Ecosystem; and Spoke 7-Innovating Transla-tional Me…
- The National Recovery and Resilience Plan, part of the Next Generation EU program, PNRR THE—Tuscany Health Ecosystem; Spoke 7—Innovating Translational Medicine…
Zitieren
APA
Bianchi, M., Esin, S., Kaya, E., Batoni, G., & Maisetta, G. (2024). Anti-Persisters Activity of Lacticaseibacillus rhamnosus Culture Filtrates against Pseudomonas aeruginosa in Artificial Sputum Medium. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137113
Vancouver
Bianchi M, Esin S, Kaya E, Batoni G, Maisetta G. Anti-Persisters Activity of Lacticaseibacillus rhamnosus Culture Filtrates against Pseudomonas aeruginosa in Artificial Sputum Medium. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137113
BibTeX
@article{Bianchi2024,
author = {Bianchi, Marta and Esin, Semih and Kaya, Esingül and Batoni, Giovanna and Maisetta, Giuseppantonio},
title = {Anti-Persisters Activity of Lacticaseibacillus rhamnosus Culture Filtrates against Pseudomonas aeruginosa in Artificial Sputum Medium},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137113}
}
EUVIMED